Relationship between ABO blood type and clinical–pathological characteristics with prostate cancer patients in Khartoum state, Khartoum, Sudan

Main Article Content

Wafa Mobarak Ahmed Ali
Asim Alaaedin Osman
Gad Allah Modawe


ABO blood group, prostate cancer, clinical pathology, Sudanese


Background: Recent studies have demonstrated the association between ABO blood group and prostate cancer (PC), as well as the various factors associated with PC, including age, family history, ethnicity, and certain viruses. Aim: To demonstrate the association between ABO blood groups and PC and to correlate it with the demographic and clinical features of our studied population. Methods: A descriptive cross-sectional hospital-based study was conducted at the Radiation and Isotopes Center—Khartoum (RICK) in Khartoum state from April 2018 to April 2019. From a study population of 389 PC patients (RICK), a total of 101 were selected. Data was analyzed using SPSS version 21. Results: The mean age of prostate cancer was 66.3 ± 7.8 years; hypertension was the most common chronic disease, affecting 62.3% (63) of patients. Prostate-specific antigen levels increased by more than 10 ng/ml among 74.3% (75) of PC patients. Patients with blood group O had slightly more than one-third, or 37.6% (38), whereas patients with other blood groups had similar percentage ranging from 20% to 22%. No significant relationship was found between ABO blood groups and clinical–pathological characteristics with PC (P-value = 0.067). Conclusion: Our study provides evidence of an association between ABO blood group and clinical–pathological features of PC, hypertension was common in patients with ABO blood group, and there was no significant relationship between ABO blood group and clinical–pathological characteristics of PC.

Abstract 294 | Full PDF Downloads 85


1. Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63–89.
2. Taitt HE. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health. 2018;12(6):1807–23.
3. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res. 2009;53(2):171–84.
4. Larson NB, Bell EJ, Decker PA, et al. ABO blood group associations with markers of endothelial dysfunction in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2016;251:422–9.
5. Dean L. Blood groups and red cell antigens [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2005. Chapter 2, Blood group antigens are surface markers on the red blood cell membrane. Available from:
6. Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1953 Apr 11;1(4814):799–801.
7. Wolpin BM, Chan AT, Hartge P, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst. 2009;101(6):424–31.
8. Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer. 2011;128(2):482–6.
9. Joh HK, Cho E, Choueiri TK. ABO blood group and risk of renal cell cancer. Cancer Epidemiol. 2012;36(6):528–32.
10. Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PLoS One. 2010;5(8):e11972.
11. Huang JY, Wang R, Gao YT, Yuan JM. ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study. PLoS One. 2017;12(9):e0184295.
12. Markt SC, Shui IM, Unger RH, et al. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3). Prostate. 2015;75(15):1677–81.
13. Stakišaitis D, Juknevičienė M, Ulys A, et al. ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. Oncol Lett. 2018;16(1):1321–31.
14. Amany E., Muntaser EI, Dafalla A, Kamal EHM, Sulma IM. Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers. Cancer Med. 2015 Mar;4(3):447–56.
15. Ekman P. Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts. Eur Urol. 1999;35(5-6):362–9. doi:10.1159/000019910. PMID: 10325490.
16. Moawia MAE. Personal perspective: access to treatment for gynaecological malignancies in Sudan. South Afr J Gynaecol Oncol. 2018;10(2):21–3.
17. Gorish B, Ournasseir M, Shammat I: Effect of Age, Geographical Affiliation and Environmental Factors on the Development of Prostate Cancer among Sudanese Patients. J Carcinog Mutagen. 2019;10(3):337.
18. Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P. Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Ann Oncol. 2018 Feb 1;29(2):377–85.
19. Raval AD, Madhavan S, Mattes MD, Sambamoorthi U. Association between types of chronic conditions and cancer stage at diagnosis among elderly Medicare beneficiaries with prostate cancer. Popul Health Manag. 2016 Dec;19(6):445–53.
20. Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus. 2016;14(5):434–40. doi:10.2450/2015.0164-15
21. Shankar S, Prasad C. Clinicopathological study of ABO blood types in prostate cancer. Indian J Pathol Oncol. 2018;5(4):675–9.
22. Markt SC, Shui IM, Unger RH, Urun Y, Berg CD, Black A, et al. ABO blood group alleles and prostate cancer risk: results from the breast and prostate cancer cohort consortium (BPC3). Prostate. 2015;75(15):1677–81.
23. Seth KR, Rachel EE. The role of the histoblood ABO group in cancer. Future Sci OA. 2026 Mar 15;2(2):fso107. doi:10.4155/fsoa-2015-0012
24. Mansour A, Mohammed MA, Anwar R, Elzafrany M, Omar N. ABO blood group and risk of malignancies in Egyptians. Int J Cancer Res. 2014;10(2):81–95.
25. Güner Şİ, Güner E. ABO blood types and risk of testicular cancer in Turkish population: preliminary results. Bull Urooncol. 2019;18:135–7.
26. Zhang B-L, He N, Huang Y-B, Song F-J, Chen K-X. ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2014;15(11):4643–50.
27. Hsiao L-T, Liu N-J, You S-L, Hwang L-C. ABO blood group and the risk of cancer among middle‐aged people in Taiwan. Asia Pac J Clin Oncol. 2015;11(4):e31–6.
28. Wang F-M, Zhang Y, Zhang G-M, Liu Y-N, Sun L-J, Liu Y. Association of ABO blood types and clinicopathological features of prostate cancer. Dis Markers. 2017;2017:9237481.
29. Rummel, Seth K; Ellsworth, Rachel E The role of the histoblood ABO group in cancer. Future Science OA,2016: 2(2), fsoa-2015-0012–. doi:10.4155/fsoa-2015-0012.

Similar Articles

1-10 of 64

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>